Clarivate Launches AI-powered Regulatory Assistant Within Cortellis Suite to Boost Productivity and Ease Regulatory Burden
Clarivate (NYSE:CLVT) has announced the beta launch of its AI-powered Regulatory Assistant within the Cortellis Regulatory Intelligence platform. The new tool, set for full release in September, aims to help regulatory professionals in biopharma, medtech, and research organizations navigate complex global requirements more efficiently.
The AI Assistant features include conversational AI with referenced answers, chat history functionality, and multilingual capabilities. The solution has been developed with input from industry partners, including Moderna, and builds on Clarivate's 30+ years of regulatory expertise and proven AI platform that powers other solutions like Web of Science.
Clarivate (NYSE:CLVT) ha annunciato il lancio in beta del suo Assistente Normativo basato sull'IA all'interno della piattaforma Cortellis Regulatory Intelligence. Il nuovo strumento, previsto per il rilascio completo a settembre, mira ad aiutare i professionisti regolatori nei settori biofarmaceutico, medtech e nelle organizzazioni di ricerca a districarsi in modo pi霉 efficiente tra i complessi requisiti normativi globali.
Le funzionalit脿 dell'Assistente IA includono IA conversazionale con risposte referenziate, cronologia chat e capacit脿 multilingue. La soluzione 猫 stata sviluppata con il contributo di partner del settore, tra cui Moderna, e si basa sui oltre 30 anni di esperienza regolatoria di Clarivate e sulla sua piattaforma IA collaudata che alimenta altre soluzioni come Web of Science.
Clarivate (NYSE:CLVT) ha anunciado el lanzamiento beta de su Asistente Regulatorio impulsado por IA dentro de la plataforma Cortellis Regulatory Intelligence. La nueva herramienta, con lanzamiento completo previsto para septiembre, pretende ayudar a los profesionales regulatorios de biof谩rmacos, medtech y organizaciones de investigaci贸n a navegar con mayor eficiencia los complejos requisitos globales.
El asistente IA incluye IA conversacional con respuestas referenciadas, historial de chat y capacidades multiling眉es. La soluci贸n se ha desarrollado con aportes de socios del sector, entre ellos Moderna, y se apoya en los m谩s de 30 a帽os de experiencia regulatoria de Clarivate y en su plataforma de IA probada que impulsa otras soluciones como Web of Science.
Clarivate (NYSE:CLVT)臧� Cortellis Regulatory Intelligence 頂岆灚韽� 雮挫棎靹� AI 旮半皹 攴滌牅 氤挫“鞚�鞚� 氩犿儉 氩勳爠鞚� 氚滍憸頄堨姷雼堧嫟. 鞚� 霃勱惮電� 9鞗� 鞝曥嫕 於滌嫓毳� 氇╉憸搿� 頃橂┌, 氚旍澊鞓ろ寣毵埪冯⿺霌滍厡韥� 氚� 鞐瓣惮 旮瓣磤鞚� 攴滌牅 雼措嫻鞛愱皜 氤奠灐頃� 旮�搿滊矊 攴滌牅 鞖旉贝鞚� 氤措嫟 須湪鞝侅溂搿� 韺岇晠頃橂弰搿� 霃曤姅 瓴冹潉 氇╈爜鞙茧 頃╇媹雼�.
AI 氤挫“鞚胳潣 旮半姤鞐愲姅 彀戈碃 於滌矘臧� 韽暔霅� 雽�頇旐槙 AI 鞚戨嫷, 毂勴寘 旮半 旮半姤 氚� 雼り淡鞏� 歆�鞗愳澊 韽暔霅╇媹雼�. 鞚� 靻旊（靺橃潃 Moderna毳� 韽暔頃� 鞐呹硠 韺岉姼雱堧摛鞚� 鞚橁铂鞚� 氚橃榿頃� 臧滊皽霅橃棃鞙茧┌, Clarivate鞚� 30雲� 鞚挫儊鞚� 攴滌牅 鞝勲靹标臣 Web of Science 霌� 雼るジ 靻旊（靺橃潉 霋冯皼旃晿電� 瓴�歃濍悳 AI 頂岆灚韽检潉 旮半皹鞙茧 頃╇媹雼�.
Clarivate (NYSE:CLVT) a annonc茅 le lancement en version b锚ta de son Assistant r茅glementaire aliment茅 par l'IA au sein de la plateforme Cortellis Regulatory Intelligence. Le nouvel outil, dont la sortie compl猫te est pr茅vue en septembre, vise 脿 aider les professionnels de la r茅glementation dans la biopharmacie, la medtech et les organismes de recherche 脿 mieux s'y retrouver face aux exigences mondiales complexes.
Les fonctionnalit茅s de l'Assistant IA incluent une IA conversationnelle avec r茅ponses r茅f茅renc茅es, l'historique des conversations et des capacit茅s multilingues. La solution a 茅t茅 d茅velopp茅e avec l'apport de partenaires du secteur, dont Moderna, et s'appuie sur plus de 30 ans d'expertise r茅glementaire de Clarivate ainsi que sur sa plateforme IA 茅prouv茅e qui alimente d'autres solutions comme Web of Science.
Clarivate (NYSE:CLVT) hat die Beta-Einf眉hrung seines KI-gest眉tzten Regulierungsassistenten innerhalb der Cortellis Regulatory Intelligence Plattform angek眉ndigt. Das neue Tool, das im September vollst盲ndig ver枚ffentlicht werden soll, zielt darauf ab, Regulierungsfachkr盲fte in der Biopharma-, Medizintechnik- und Forschungsbranche dabei zu unterst眉tzen, komplexe globale Anforderungen effizienter zu bew盲ltigen.
Zu den Funktionen des KI-Assistenten geh枚ren konversationelle KI mit referenzierten Antworten, Chatverlaufsfunktionen und Mehrsprachigkeit. Die L枚sung wurde mit Beitr盲gen von Branchenpartnern, darunter Moderna, entwickelt und baut auf Clarivates 眉ber 30-j盲hriger Regulierungsexpertise sowie der erprobten KI-Plattform auf, die auch andere L枚sungen wie Web of Science unterst眉tzt.
- Integration of AI technology to streamline regulatory compliance workflows
- Partnership with major industry players like Moderna for beta testing
- Built on established Clarivate AI platform with 30+ years of regulatory expertise
- None.
Insights
Clarivate's new AI Regulatory Assistant strengthens its competitive position in life sciences intelligence, potentially boosting recurring revenue from subscription upgrades.
Clarivate's beta launch of an AI-powered Regulatory Assistant within its Cortellis Regulatory Intelligence platform represents a strategic enhancement to one of its core product offerings. The timing is particularly relevant as regulatory teams across pharma and medtech face increasing complexity in global compliance requirements. This AI capability directly addresses significant pain points in regulatory workflows - specifically the time-consuming process of searching through vast regulatory databases and interpreting complex requirements.
The product incorporates several valuable capabilities that differentiate it in the market: conversational AI with referenced answers, persistent conversation history, and multilingual support. These features align with enterprise demands for more efficient regulatory intelligence tools. Importantly, the solution is built on Clarivate's existing AI infrastructure that powers other products like Web of Science, suggesting efficient R&D resource allocation rather than building from scratch.
Endorsement from Moderna, a high-profile customer, provides external validation and indicates potential market reception. The September full release timeline suggests confidence in the technology's readiness. For Clarivate's business model, which relies heavily on recurring subscription revenue, this enhancement could strengthen customer retention while potentially enabling premium pricing or upselling opportunities for the enhanced Cortellis platform. This aligns with the broader industry trend of embedding AI capabilities into enterprise software to improve stickiness and justify subscription increases.
Integrated into Cortellis Regulatory Intelligence, new AI capability helps regulatory teams streamline access to critical intelligence and understand requirements with ease
Features within the Beta version of Cortellis Regulatory Intelligence AI Assistant include:
- Conversational AI with referenced answers: Users can ask regulatory questions naturally and get precise, cited responses, saving hours of manual work. The AI-powered Assistant, guided by domain expertise, understands regulatory nuances to provide customers with accurate answers.
- Your conversations, always within reach: Users can pick up right where they left off with chat history, resulting in more relevant, personalized responses.
- Multilingual by design: Search and interact in preferred languages for a seamless, tailored experience.
Yuval Kiselstein, VP, R&D, Life Sciences & Healthcare at Clarivate, said: "Today's regulatory environment is increasingly complex and fast-changing. The beta launch of the Regulatory Assistant is a key milestone in our mission to empower regulatory teams with intuitive, AI-driven tools that enhance productivity and support confident, compliant decision-making. By working closely with our Collaborative Partners, we are building a solution that reflects real-world workflows and priorities."
Janeen Skutnik-Wilkinson, Director, Regulatory Intelligence & External Engagement, Moderna, said: "We are so pleased to be a part of the beta testing for the new AI Regulatory assistant. This tool will save us significant time and resources compared to searching manually, and we are already seeing how this will speed up internal enquiries and intelligence work. We have been impressed with how the team is actively engaging clients in the development process by seeking out and acting upon our feedback to continually improve the product. They are dedicated to building a useful tool that meets our needs while ensuring that it is also accurate and user-friendly."
With market-leading intelligence solutions, transformative data technologies and trusted AI, Clarivate equips customers with the insight and foresight they need across every stage of the product lifecycle, from early discovery through commercialization and beyond. In line with this commitment, the new AI-powered Regulatory Assistant brings the Clarivate mission to life by helping customers navigate complexity, accelerate decision-making and shape the future of healthcare.
As regulatory professionals face mounting pressure to keep pace with global changes, interpret complex requirements, and ensure compliance, the Regulatory Assistant streamlines access to trusted intelligence, enabling faster, more confident decisions. Built on the same proven Clarivate AI platform that powers Clarivate solutions, including听, and trusted by hundreds of organizations, it combines powerful technology with 30+ years of regulatory expertise relied on by top pharma and global agencies.
To learn more about the Cortellis Regulatory Intelligence AI-powered Regulatory Assistant, visit .
About Clarivate
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare.听 For more information, please visit 听
Media Contact:
Catherine Daniel
Director, External Communications, Life Sciences & Healthcare
Clarivate
[email protected]
View original content to download multimedia:
SOURCE Clarivate Plc
FAQ
What is Clarivate's new AI-powered Regulatory Assistant and when will it be available?
What are the key features of Clarivate's new AI Regulatory Assistant?
How does Clarivate's AI Regulatory Assistant benefit pharmaceutical companies?
Who is involved in testing Clarivate's new AI Regulatory Assistant?
What technology powers Clarivate's AI Regulatory Assistant?
